Effects of galcanezumab on acute medication use and health care resource utilization in treatment-resistant migraine: results from randomized, double blind, placebo-controlled clinical trial, conquer. Headache Medicine, [S. l.], v. 11, n. Supplement, p. 27, 2020. DOI: 10.48208/HeadacheMed.2020.Supplement.27. Disponível em: https://headachemedicine.com.br/hm/article/view/112. Acesso em: 22 jan. 2026.